Aberrant expression of MMP12 was reported in several types of cancers, including hepatocellular carcinoma (He et al., 2018), lung cancer (Roman, 2017), colon cancer (Klupp et al., 2016) and nasopharyngeal carcinoma (Chung et al., 2014). This evidence concerns the gene MMP12 and nasopharyngeal carcinoma.